Protective roles of quinone reductase and tamoxifen against estrogen-induced mammary tumorigenesis

Oncogene

Volumn 26, Issue 24, 2007, Pages 3587-3590

  Montano, M M ^a   Chaplin, L J ^a   Deng, H ^a   Mesia Vela, S ^b   Gaikwad, N ^c   Zahid, M ^c   Rogan, E ^c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Antiestrogens; Estrogen; Estrogen receptor ; Mammary gland; Oxidative damage; Quinone reductase

Indexed keywords

4 HYDROXYTAMOXIFEN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR BETA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); TAMOXIFEN CITRATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CELL TRANSFORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DRUG MECHANISM; EPITHELIUM CELL; ESTROGEN METABOLISM; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METABOLITE; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION;

ANIMALS; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; DEOXYGUANOSINE; DNA DAMAGE; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR BETA; ESTROGENS; HUMANS; MAMMARY GLANDS, ANIMAL; NAD(P)H DEHYDROGENASE (QUINONE); OXIDATIVE STRESS; RATS; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 34249309939     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210144     Document Type: Article

References (19)

1. Ansell PJ, Espinosa-Nicholas C, Curran EM, Judy BM, Philips BJ, Hannink M et al. (2004). In vitro and in vivo regulation of antioxidant response element-dependent gene expression by estrogens. Endocrinology 145: 311-317.
2. Bianco NR, Perry G, Smith MA, Templeton DJ, Montano MM. (2003). Functional implications of antiestrogen induction of quinone reductase: inhibition of estrogen-induced DNA damage. Mol Endocrinol 17: 1344-1355.
3. Dawson PJ, Wolman SR, Tait L, Heppner GH, Miller FR. (1996). MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am J Pathol 148: 313-319.
4. Guo M, Joiakim A, Dudley DT, Reiners JJ. (2001). Suppression of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated CYP1A1 and CYP1B1 induction by 12-O-tetradecanoylphorbol-13-acetate: role of transforming growth factor beta and mitogen-activated protein kinases. Biochem Pharmacol 62: 1449-1457.
5. Harvell DM, Strecker TE, Tochacek M, Xie B, Pennington KL, McComb RD et al. (2000). Rat strain-specific actions of 17beta-estradiol in the mammary gland: correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers. Proc Natl Acad Sci USA 97: 2779-2784.
6. Helbock HJ, Beckman KB, Ames BN. (1999). 8-Hydroxydeoxyguanosine and 8-hydroxyguanine as biomarkers of oxidative DNA damage. Methods Enzymol 300: 156-166.
7. Jefcoate CR, Liehr JG, Santen RJ, Sutter TR, Yager JD, Yue W et al. (2000). Tissue-specific synthesis and oxidative metabolism of estrogens. J Natl Cancer Inst Monogr 27: 95-112.
8. Jones SB, Brooks JD. (2006). Modest induction of phase 2 enzyme activity in the F-344 rat prostate. BMC Cancer 6: 62-70.
9. Kassie F, Uhl M, Rabot S, Grasl-Kraupp B, Verkerk R, Kundi M et al. (2003). Chemoprevention of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-induced colonic and hepatic preneoplastic lesions in the F344 rat by cruciferous vegetables administered simultaneously with the carcinogen. Carcinogenesis 24: 255-261.
10. Li JJ, Papa D, Davis MF, Weroha SJ, Aldaz CM, El-Bayoumy K et al. (2002a). Ploidy differences between hormone- and chemical carcinogen-induced rat mammary neoplasms: comparison to invasive human ductal breast cancer. Mol Carcinog 33: 56-65.
11. Li SA, Weroha SJ, Tawfik O, Li JJ. (2002b). Prevention of solely estrogen-induced mammary tumors in female aci rats by tamoxifen: evidence for estrogen receptor mediation. J Endocrinol 175: 297-305.
12. Liehr JG. (2000). Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 21: 40-54.
13. Matusheski NV, Jeffery EH. (2001). Comparison of the bioactivity of two glucoraphanin hydrolysis products found in broccoli, sulforaphane and sulforaphane nitrile. J Agric Food Chem 49: 5743-5749.
14. Montano MM, Deng H, Liu M, Sun X, Singal R. (2004). Transcriptional regulation by the estrogen receptor of antioxidative stress enzymes and its functional implications. Oncogene 23: 2442-2453.
15. Montano MM, Jaiswal AK, Katzenellenbogen BS. (1998). Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-alpha and estrogen receptor-beta. J Biol Chem 273: 25443-25449.
16. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK et al. (2001). Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60: 759-767.
17. Rogan EG, Badawi AF, Devanesan PD, Meza JL, Edney JA, West WW et al. (2003). Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer. Carcinogenesis 24: 697-702.
18. Saji S, Jensen EV, Nilsson S, Rylander T, Warner M, Gustafsson JA. (2000). Estrogen receptors and in the rodent mammary gland. Proc Natl Acad Sci USA 97: 337-342.
19. Thomas RD, Green MR, Wilson C, Weckle AL, Duanmu Z, Kocarek TA et al. (2006). Cytochrome P450 expression and metabolic activation of cooked food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in MCF10A breast epithelial cells. Chem Biol Interact 160: 204-216.